Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Characterization of Calflagin, a Flagellar Calcium-Binding Protein from Trypanosoma congolense.

Eyford BA, Kaufman L, Salama-Alber O, Loveless B, Pope ME, Burke RD, Matovu E, Boulanger MJ, Pearson TW.

PLoS Negl Trop Dis. 2016 Apr 7;10(4):e0004510. doi: 10.1371/journal.pntd.0004510. eCollection 2016 Apr.

2.

Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole.

Fernández ML, Marson ME, Ramirez JC, Mastrantonio G, Schijman AG, Altcheh J, Riarte AR, Bournissen FG.

Mem Inst Oswaldo Cruz. 2016 Mar;111(3):218-21. doi: 10.1590/0074-02760150401. Epub 2016 Mar 15.

3.

The BENEFIT Trial: Where Do We Go from Here?

Pecoul B, Batista C, Stobbaerts E, Ribeiro I, Vilasanjuan R, Gascon J, Pinazo MJ, Moriana S, Gold S, Pereiro A, Navarro M, Torrico F, Bottazzi ME, Hotez PJ.

PLoS Negl Trop Dis. 2016 Feb 25;10(2):e0004343. doi: 10.1371/journal.pntd.0004343. eCollection 2016 Feb. No abstract available.

4.

Preventing the transmission of American trypanosomiasis and its spread into non-endemic countries.

Liu Q, Zhou XN.

Infect Dis Poverty. 2015 Dec 28;4:60. doi: 10.1186/s40249-015-0092-7. Review.

5.

New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: a Pilot Short-Term Follow-Up Study with Adult Patients.

Álvarez MG, Hernández Y, Bertocchi G, Fernández M, Lococo B, Ramírez JC, Cura C, Albizu CL, Schijman A, Abril M, Sosa-Estani S, Viotti R.

Antimicrob Agents Chemother. 2015 Nov 23;60(2):833-7. doi: 10.1128/AAC.00745-15.

PMID:
26596935
6.

Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.

Sguassero Y, Cuesta CB, Roberts KN, Hicks E, Comandé D, Ciapponi A, Sosa-Estani S.

PLoS One. 2015 Oct 5;10(10):e0139363. doi: 10.1371/journal.pone.0139363. eCollection 2015.

7.

Modulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas disease.

Albareda MC, Laucella SA.

Mem Inst Oswaldo Cruz. 2015 May;110(3):414-21. doi: 10.1590/0074-02760140386. Review.

8.

Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives.

Pinazo MJ, Thomas MC, Bustamante J, Almeida IC, Lopez MC, Gascon J.

Mem Inst Oswaldo Cruz. 2015 May;110(3):422-32. doi: 10.1590/0074-02760140435. Epub 2015 Apr 28. Review.

9.

Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia.

Bianchi F, Cucunubá Z, Guhl F, González NL, Freilij H, Nicholls RS, Ramírez JD, Montilla M, Flórez AC, Rosas F, Saavedra V, Silva N.

PLoS Negl Trop Dis. 2015 Feb 27;9(2):e0003465. doi: 10.1371/journal.pntd.0003465. eCollection 2015 Feb.

10.

Prevalence of Chagas disease in Latin-American migrants living in Europe: a systematic review and meta-analysis.

Requena-Méndez A, Aldasoro E, de Lazzari E, Sicuri E, Brown M, Moore DA, Gascon J, Muñoz J.

PLoS Negl Trop Dis. 2015 Feb 13;9(2):e0003540. doi: 10.1371/journal.pntd.0003540. eCollection 2015 Feb. Review.

11.

Seroprevalence of Trypanosoma cruzi among mothers and children in rural Mayan communities and associated reproductive outcomes.

Gamboa-León R, Ramirez-Gonzalez C, Pacheco-Tucuch FS, O'Shea M, Rosecrans K, Pippitt J, Dumonteil E, Buekens P.

Am J Trop Med Hyg. 2014 Aug;91(2):348-53. doi: 10.4269/ajtmh.13-0527. Epub 2014 Jun 16.

12.

Serum biomarkers predictive of cure in Chagas disease patients after nifurtimox treatment.

Santamaria C, Chatelain E, Jackson Y, Miao Q, Ward BJ, Chappuis F, Ndao M.

BMC Infect Dis. 2014 Jun 3;14:302. doi: 10.1186/1471-2334-14-302.

13.

Population pharmacokinetic study of benznidazole in pediatric Chagas disease suggests efficacy despite lower plasma concentrations than in adults.

Altcheh J, Moscatelli G, Mastrantonio G, Moroni S, Giglio N, Marson ME, Ballering G, Bisio M, Koren G, García-Bournissen F.

PLoS Negl Trop Dis. 2014 May 22;8(5):e2907. doi: 10.1371/journal.pntd.0002907. eCollection 2014 May.

14.

Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development.

Moraes CB, Giardini MA, Kim H, Franco CH, Araujo-Junior AM, Schenkman S, Chatelain E, Freitas-Junior LH.

Sci Rep. 2014 Apr 16;4:4703. doi: 10.1038/srep04703.

15.

Treatment of Chagas cardiomyopathy.

Botoni FA, Ribeiro AL, Marinho CC, Lima MM, Nunes Mdo C, Rocha MO.

Biomed Res Int. 2013;2013:849504. doi: 10.1155/2013/849504. Epub 2013 Nov 24. Review.

16.

Towards a paradigm shift in the treatment of chronic Chagas disease.

Viotti R, Alarcón de Noya B, Araujo-Jorge T, Grijalva MJ, Guhl F, López MC, Ramsey JM, Ribeiro I, Schijman AG, Sosa-Estani S, Torrico F, Gascon J; Latin American Network for Chagas Disease, NHEPACHA.

Antimicrob Agents Chemother. 2014;58(2):635-9. doi: 10.1128/AAC.01662-13. Epub 2013 Nov 18.

17.

A serological, parasitological and clinical evaluation of untreated Chagas disease patients and those treated with benznidazole before and thirteen years after intervention.

Machado-de-Assis GF, Diniz GA, Montoya RA, Dias JC, Coura JR, Machado-Coelho GL, Albajar-Viñas P, Torres RM, Lana Md.

Mem Inst Oswaldo Cruz. 2013 Nov;108(7):873-80. doi: 10.1590/0074-0276130122.

18.

Clinical follow-up of responses to treatment with benznidazol in Amazon: a cohort study of acute Chagas disease.

Pinto AY, Valente Vda C, Coura JR, Valente SA, Junqueira AC, Santos LC, Ferreira AG Jr, de Macedo RC.

PLoS One. 2013 May 27;8(5):e64450. doi: 10.1371/journal.pone.0064450. Print 2013.

19.

Is Chagas disease really the "new HIV/AIDS of the Americas"?

Tarleton RL, Curran JW.

PLoS Negl Trop Dis. 2012;6(10):e1861. doi: 10.1371/journal.pntd.0001861. Epub 2012 Oct 25. No abstract available.

20.

Benznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic chagas disease.

Pinazo MJ, Guerrero L, Posada E, Rodríguez E, Soy D, Gascon J.

Antimicrob Agents Chemother. 2013 Jan;57(1):390-5. doi: 10.1128/AAC.01401-12. Epub 2012 Oct 31.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk